Funding to Overcome Consequences of Natural Calamity

Recently, the storm No. 11 landed in the central provinces of Vietnam caused severe devastation, materially as well as mentally, to the residents therein. Among the said provinces, Phu Yen suffered the most severe damages with the total economic losses estimated VND 2,500 billion. In addition, there were 70 fatalities, 17 missing, thousands of collapsed houses and some ten thousands of damaged ones. As a result, many people were left homeless.

Having a part in the movement to share ups and downs with victims of storm No. 11, STADA-VN recently aided the region with 10 tons of rice (costing 85 million VND) as a post-disaster relief for the hopeless people of Phu Yen.

STADA-VN sincerely hopes that the said contribution shall result in a meaningful relief to the misfortunate people in need after calamity.

STADA-VN is dedicated to helping by funding necessary efforts to overcome consequences of natural calamity.

 

***

About STELLA

STELLA Pharma J.V. Co., Ltd., Binh Duong Branch, formerly known as STADA – VN J.V. Co., Ltd., Binh Duong Branch (the “STELLA” or “Factory II“), located at Vietnam – Singapore Industrial Park, Binh Duong and the Factory II was recognized as a pharma facility complying with European Good Manufacturing Practice issued by European Medicines Agency, Germany (the “EMA“).

Additional information for this article: 
STELLA Pharma J.V. Co., Ltd., | 40 Tu Do Avenue, VSIP, An Phu, Thuan An, Binh Duong.
Tel: +84 274 376 7470 | Fax: +84 274 376 7469 | E-Mail: info@stellapharm.com

You May like

13 Dec 2024

VIETNAM AIMS TO PRODUCE INNOVATIVE MEDICINES

The Ministry of Health has proposed a policy to encourage the transfer of new and innovative drugs, aiming to create more opportunities for patients. According to the ministry’s Drug Administration of Vietnam (DAV), innovative drugs in Vietnam account for only about 3% of the total but represent up to 22% of the value and are

27 Nov 2024

VIỆT NAM SEEKS TO SPEED UP NEW DRUG ACCESS

A draft version of the revised Pharmacy Law will be presented to the ongoing National Assembly session to enhance public access to new medicines. Only 9% of new medicines have been introduced in Việt Nam over the past decade, far lower than that in other Asia-Pacific countries (20%). The Head of Legal and Integration Department